Neo-adjuvant therapy and surgical decision making in breast cancer
Neo-adjuvant therapy and surgical decision making in breast cancer
Nurse's perspective on PARP inhibitors and personalised medicine in prostate cancer
ITACA NSCLC study: Final results
Renal liposarcoma: Case report and review of systemic treatment
Updates on managing HER2-positive early breast cancer
Managing HER2-positive breast cancer
Management of axilla after neo-adjuvant treatment
KEYNOTE-598: pembrolizumab with ipilimumab or placebo in patients with untreated metastatic NSCLC
TALAPRO-1: phase II study of talazoparib in patients with DNA damage repair alterations and mCRPC
ASCO GU 2021: Renal cancer roundup
OncoAlert and ecancer weekly roundup for February 07 - 13, 2021
COVID-19 pandemic threatens global life-saving gains in childhood cancer